Deng Kaige, Xing Jiali, Xu Gang, Ma Ruixue, Jin Bao, Leng Zijian, Wan Xueshuai, Xu Jingyong, Shi Xiaolei, Qiao Jiangchun, Yang Jiayin, Song Jinghai, Zheng Yongchang, Sang Xinting, Du Shunda
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Department of Liver Surgery and Liver Transplant Center, Department of General of Surgery, West China Hospital of Sichuan University, Chengdu, China.
World J Surg Oncol. 2024 Oct 1;22(1):263. doi: 10.1186/s12957-024-03533-z.
Gallbladder cancer (GBC) is a highly aggressive malignancy, with limited survival profiles after curative surgeries. This study aimed to develop a practical model for predicting the postoperative overall survival (OS) in GBC patients.
Patients from three hospitals were included. Two centers (N = 102 and 100) were adopted for model development and internal validation, and the third center (N = 85) was used for external testing. Univariate and stepwise multivariate Cox regression were used for feature selection. A nomogram for 1-, 3-, and 5-year postoperative survival rates was constructed accordingly. Performance assessment included Harrell's concordance index (C-index), receiver operating characteristic (ROC) curves and calibration curves. Kaplan-Meier curves were utilized to evaluate the risk stratification results of the nomogram. Decision curves were used to reflect the net benefit.
Eight factors, TNM stage, age-adjusted Charlson Comorbidity Index (aCCI), body mass index (BMI), R0 resection, blood platelet count, and serum levels of albumin, CA125, CA199 were incorporated in the nomogram. The time-dependent C-index consistently exceeded 0.70 from 6 months to 5 years, and time-dependent ROC revealed an area under the curve (AUC) of over 75% for 1-, 3-, and 5-year survival. The calibration curves, Kaplan-Meier curves and decision curves also indicated good prognostic performance and clinical benefit, surpassing traditional indicators TNM staging and CA199 levels. The reliability of results was further proved in the independent external testing set.
The novel nomogram exhibited good prognostic efficacy and robust generalizability in GBC patients, which might be a promising tool for aiding clinical decision-making.
胆囊癌(GBC)是一种侵袭性很强的恶性肿瘤,根治性手术后的生存情况有限。本研究旨在建立一个实用模型来预测GBC患者术后的总生存期(OS)。
纳入来自三家医院的患者。两个中心(n = 102和100)用于模型开发和内部验证,第三个中心(n = 85)用于外部测试。采用单因素和逐步多因素Cox回归进行特征选择。据此构建了1年、3年和5年术后生存率的列线图。性能评估包括Harrell一致性指数(C指数)、受试者工作特征(ROC)曲线和校准曲线。采用Kaplan-Meier曲线评估列线图的风险分层结果。决策曲线用于反映净效益。
列线图纳入了八个因素,即TNM分期、年龄调整后的Charlson合并症指数(aCCI)、体重指数(BMI)、R0切除、血小板计数以及血清白蛋白、CA125、CA199水平。从6个月到5年,时间依赖性C指数始终超过0.70,时间依赖性ROC显示1年、3年和5年生存率的曲线下面积(AUC)超过75%。校准曲线、Kaplan-Meier曲线和决策曲线也显示出良好的预后性能和临床效益,超过了传统指标TNM分期和CA199水平。在独立的外部测试集中进一步证明了结果的可靠性。
新型列线图在GBC患者中显示出良好的预后疗效和强大的可推广性,可能是辅助临床决策的一个有前景的工具。